Accurate IOL power challenging in refractive patients

Article

Achieving the proper IOL power for patients who have had a refractive procedure such as LASIK, PRK, or RK can be challenging, and taking more measurements leads to greater accuracy.

Achieving the proper IOL power for patients who have had a refractive procedure such as LASIK, PRK, or RK can be challenging, and taking more measurements leads to greater accuracy, said Jack T. Holladay, MD, MSEE, FACS, Holladay LASIK Institute and Baylor College of Medicine, Houston, US.

“If we’re going to promise our patients who get a multifocal lens that they’re not going to need to wear glasses, or that they’re not going to need to wear glasses for distance if they get a monofocal lens, there are a number of parameters that we’re going to have to get right,” he said.

“The trouble with arriving at the effective lens position is that we can’t measure it preoperatively because the patient still has a cataract, and we can’t choose it like we do the postoperative refraction,” Dr Holladay said. “So we have to predict [the] value.”

The first “must” in that prediction is accurate biometry, Dr Holladay said. The standard today has become optical coherence tomography, he said, adding, however, that ultrasonic measurements still are required in about 10–15% of cases because of the presence of a dense cataract.

Axial length also is an extremely important consideration, as is anterior segment size, Dr Holladay said. The two are not the same, he emphasized, and an accurate eye model must include nine types of eyes: small, normal, and large anterior segment sizes in eyes with short (<21 mm), normal, and long (>27 mm) axial lengths.

“For example, we find that 80% of short axial lengths (down to 15 mm), have a horizontal white-to-white measurement that’s normal. In other words, the anterior segment of a very short eye is almost independent of the axial length,” Dr Holliday said. “And when you take long eyes, out to 35 mm, you find that these long eyes still have 90% normal white-to-white [measurement].”

He added that, in treating patients who have undergone LASIK or PRK, ophthalmologists trying to arrive at the proper IOL power can “tighten the boundaries” slightly because the corneas in these patients are not as multifocal.

“RK patients, on the other hand, depending on how many incisions were made, how big the optical zone is, and so forth, have a lot more variability, so it's a lot harder to get the exact target,” Dr Holladay said.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.